Infinity Market Research
Infinity Market Research

Global Myasthenia Gravis Treatment Market Growth 2025-2031


Sep 2025

Healthcare

Pages: 109

LPI10590

PDF Available
Word Available
Excel Available


The global Myasthenia Gravis Treatment market size is predicted to grow from US$ 1971 million in 2025 to US$ 2915 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.


Drug therapy for MG includes: (1) acetylcholinesterase inhibitors, (2) immunosuppressants, (3) immunomodulators. Introduce and gradually increase options based on international guidelines and the clinical and immunological characteristics of patients. Surgical treatments include (1) thymectomy, (2) median sternotomy and video-assisted thoracoscopic surgery, etc.


The major factors driving the market growth are increasing prevalence of myasthenia gravis, awareness for early diagnosis of myasthenia gravis, and adoption of new treatment options for myasthenia gravis. Rising prevalence of myasthenia gravis globally is one of the major drivers for the growth of the myasthenia gravis treatment market. For example, according to the Myasthenia Gravis Foundation of America, about 20 out of every 100,000 people in the United States have myasthenia gravis, and the disease is more common in women than men. Furthermore, the incidence of myasthenia gravis is increasing worldwide.


Infinity Market Research newest research report, the ?Myasthenia Gravis Treatment Industry Forecast? looks at past sales and reviews total world Myasthenia Gravis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Myasthenia Gravis Treatment sales for 2025 through 2031. With Myasthenia Gravis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Myasthenia Gravis Treatment industry.


This Insight Report provides a comprehensive analysis of the global Myasthenia Gravis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Myasthenia Gravis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Myasthenia Gravis Treatment market.


This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Myasthenia Gravis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Myasthenia Gravis Treatment.


This report presents a comprehensive overview, market shares, and growth opportunities of Myasthenia Gravis Treatment market by product type, application, key manufacturers and key regions and countries.


Segmentation by Type:


    Monoclonal Antibodies
    Intravenous Immunoglobulin
    Other


Segmentation by Application:


    Hospital
    Specialist Clinic
    Other


This report also splits the market by region:


    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries


The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.


    Amneal Pharmaceuticals, Inc.
    Astellas Pharma, Inc.
    Avadel Pharmaceuticals PLC
    Bausch Health Companies Inc.
    CSL Behring
    CuraVac, Inc.
    Argenx SE
    GlaxoSmithKline plc
    Immunovant, Inc.
    Mitsubishi Tanabe Pharma Corp.
    Novartis AG
    Takeda Pharmaceutical Co., Ltd.
    UCB Pharma
    AstraZeneca
    F. Hoffmann-La Roche Ltd


Key Questions Addressed in this Report


What is the 10-year outlook for the global Myasthenia Gravis Treatment market?
What factors are driving Myasthenia Gravis Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Myasthenia Gravis Treatment market opportunities vary by end market size?
How does Myasthenia Gravis Treatment break out by Type, by Application?

Myasthenia Gravis Treatment Market Scope

Report AttributeDetails
Market Size (Start Year)USD XX Million
Market Size (End Year)USD XX Million
Compound Annual Growth Rate (CAGR)USD XX Million
Forecast PeriodUSD XX Million
Base YearUSD XX Million
Historical DataUSD XX Million
Key PlayersUSD XX Million

📘 Frequently Asked Questions

1. What is the market size of Global Myasthenia Gravis Treatment Market?

Answer: The global Myasthenia Gravis Treatment market size is predicted to grow from US$ 1971 million in 2025 to US$ 2915 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

2. Which regions are analyzed in the Global Myasthenia Gravis Treatment Market report?

Answer: The Global Myasthenia Gravis Treatment Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.

3. What methodology is used for forecasting of Global Myasthenia Gravis Treatment Market?

Answer: The Global Myasthenia Gravis Treatment Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.

4. Are emerging markets analyzed separately in the Global Myasthenia Gravis Treatment Market?

Answer: Yes, the Global Myasthenia Gravis Treatment Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.

5. Does the report include competitive benchmarking of Global Myasthenia Gravis Treatment Market?

Answer: Yes, Global Myasthenia Gravis Treatment Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.

6. Can I access country-level data within the Global Myasthenia Gravis Treatment Market report?

Answer: Yes, Global Myasthenia Gravis Treatment Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.

7. Can I get customized insights or data from the Global Myasthenia Gravis Treatment Market report?

Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.

🎁 This Month Only: Flat $1000 OFF

Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

Secure payment methods

🔐 Secure Payment Guaranteed

Safe checkout with trusted global payment methods.

🌟 Why Choose Infinity Market Research?

  • Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
  • Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
  • 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
  • Instant Savings:Enjoy a flat $1000 OFF on every report.
  • Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
  • Tailored Insights:Customized research that fits your industry and specific goals.

📄 Available License Types

👤 Single User
$3660
$2660
👥 Multi User
$5490
$4490
🏢 Enterprise User
$7320
$6320
Buy Now
Secure payment methods

Recent Reports

Laboratory Degassers Market

Global Laboratory Degassers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Laboratory Funnel Market

Global Laboratory Funnel market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.